Company intelligence / Profile preview

Predictive Laboratories

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

Predictive Laboratories commercialized molecular & genetic diagnostics, including FertilityDX (women's infertility diagnosis) and the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test, achieving product launch and distribution agreements in 2020. Clinical outcomes are not detailed, as these are diagnostics, not therapeutics

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Diagnostic testDevice (COVID-19 rapid antibody test)
Industry: Molecular Diagnostics

Partnerships

Wellgistics (distribution of COVID-19 antibody test)

Beyond the preview

Go deeper on Predictive Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Predictive Laboratories.

Explore the full profile